INVEGA TRINZA is a Intramuscular Injection, Suspension, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc. The primary component is Paliperidone Palmitate.
Product ID | 50458-607_1ef256dc-8107-11eb-98e1-81dffb2ca371 |
NDC | 50458-607 |
Product Type | Human Prescription Drug |
Proprietary Name | INVEGA TRINZA |
Generic Name | Paliperidone Palmitate |
Dosage Form | Injection, Suspension, Extended Release |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2015-05-19 |
Marketing Category | NDA / NDA |
Application Number | NDA207946 |
Labeler Name | Janssen Pharmaceuticals, Inc |
Substance Name | PALIPERIDONE PALMITATE |
Active Ingredient Strength | 410 mg/1.315mL |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2015-05-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA207946 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-05-19 |
Ingredient | Strength |
---|---|
PALIPERIDONE PALMITATE | 410 mg/1.315mL |
SPL SET ID: | c39e65d7-fa44-4e4c-8b12-a654d3ed0eae |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50458-606 | INVEGA TRINZA | paliperidone palmitate |
50458-607 | INVEGA TRINZA | paliperidone palmitate |
50458-608 | INVEGA TRINZA | paliperidone palmitate |
50458-609 | INVEGA TRINZA | INVEGA TRINZA |
50458-560 | INVEGA SUSTENNA | paliperidone palmitate |
50458-561 | INVEGA SUSTENNA | paliperidone palmitate |
50458-562 | INVEGA SUSTENNA | paliperidone palmitate |
50458-563 | INVEGA SUSTENNA | paliperidone palmitate |
50458-564 | INVEGA SUSTENNA | paliperidone palmitate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INVEGA TRINZA 86500977 4838342 Live/Registered |
JOHNSON & JOHNSON 2015-01-12 |